These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 31100555)

  • 1. Factors Associated with Physician-Patient Discordance in the Perception of Asthma Control.
    Matsunaga K; Hamada K; Oishi K; Yano M; Yamaji Y; Hirano T
    J Allergy Clin Immunol Pract; 2019; 7(8):2634-2641. PubMed ID: 31100555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study.
    Pinnock H; Burton C; Campbell S; Gruffydd-Jones K; Hannon K; Hoskins G; Lester H; Price D
    Prim Care Respir J; 2012 Sep; 21(3):288-94. PubMed ID: 22751737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of a brief asthma control screening tool in community pharmacy: a cross-sectional and prospective longitudinal analysis.
    LeMay KS; Armour CL; Reddel HK
    Prim Care Respir J; 2014 Mar; 23(1):79-84. PubMed ID: 24570084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance between pain specialists and patients on the perception of dependence on pain medication: A multi-centre cross-sectional study.
    Roussin A; Cissé Z; Rousseau V; Roche G; Lestrade C; Cauchie A; Delage N; Donnet A; Van Obberghen E; Wood C; Lapeyre-Mestre M; Cantagrel N
    Therapie; 2024 Apr; ():. PubMed ID: 38653623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How well do patients and providers agree on the severity of dyspnea?
    Stefan MS; Priya A; Martin B; Pekow PS; Rothberg MB; Goldberg RJ; DiNino E; Lindenauer PK
    J Hosp Med; 2016 Oct; 11(10):701-707. PubMed ID: 27130579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association and correlation of patient symptom perception and asthma control - a rapid literature review.
    Neffen H; Yorgancıoğlu A; Al-Jahdali H; McLachlan S; Myers J; Bly C; Martin P; Noibi S
    Asian Pac J Allergy Immunol; 2024 Jun; ():. PubMed ID: 38877849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
    Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
    Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are key symptoms to be captured for preventing a physician's underestimation of asthma control?
    Chikumoto A; Matsunaga K; Oishi K; Hamada K; Yamaji Y; Hirano T
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):564-566. PubMed ID: 32818701
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan.
    Nagase H; Adachi M; Matsunaga K; Yoshida A; Okoba T; Hayashi N; Emoto K; Tohda Y
    Allergol Int; 2020 Jan; 69(1):53-60. PubMed ID: 31311707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese guidelines for childhood asthma 2020.
    Arakawa H; Adachi Y; Ebisawa M; Fujisawa T; ; ;
    Allergol Int; 2020 Jul; 69(3):314-330. PubMed ID: 33213779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment: a proof-of-concept study-The PRO-ART study protocol.
    Tidemandsen C; Juul Gade E; Ulrik CS; Nielsen HS; Oxlund-Mariegaard BS; Kristiansen K; Freiesleben NC; Nøhr B; Udengaard H; Backer V
    BMJ Open; 2020 Nov; 10(11):e037041. PubMed ID: 33184076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Careful Selection of Patients Is Required to Obtain Higher Potential Benefit From Mepolizumab Therapy.
    Yılmaz İ
    Chest; 2020 Nov; 158(5):2229-2230. PubMed ID: 33160530
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis.
    Andreev D; Liu M; Kachler K; Llerins Perez M; Kirchner P; Kölle J; Gießl A; Rauber S; Song R; Aust O; Grüneboom A; Kleyer A; Cañete JD; Ekici A; Ramming A; Finotto S; Schett G; Bozec A
    Ann Rheum Dis; 2021 Apr; 80(4):451-468. PubMed ID: 33148700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions.
    Kanda A; Yun Y; Bui DV; Nguyen LM; Kobayashi Y; Suzuki K; Mitani A; Sawada S; Hamada S; Asako M; Iwai H
    Allergol Int; 2021 Jan; 70(1):9-18. PubMed ID: 33243693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study.
    Park SY; Kim S; Kim JH; Kim SH; Lee T; Yoon SY; Kim MH; Moon JY; Yang MS; Jung JW; Kim JH; Choi JH; Park CS; Kim S; Lee J; Kwon JW; Hur GY; Kim SH; Kim HK; Shin YS; Kim SH; Nam YH; Jang AS; Park SY; Kim TB;
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1304-1311.e2. PubMed ID: 33184024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics.
    Jabbal S; Kuo CR; Lipworth B
    Clin Exp Allergy; 2020 Oct; 50(10):1140-1147. PubMed ID: 33180376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab.
    Landi C; Cameli P; Vantaggiato L; Bergantini L; d'Alessandro M; Perruzza M; Carleo A; Shaba E; Di Giuseppe F; Angelucci S; Bargagli E; Bini L
    Biochim Biophys Acta Proteins Proteom; 2021 Feb; 1869(2):140563. PubMed ID: 33176218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Dyspnea Evaluation System Focusing on Patients' Perceptions of Dyspnea and Their Living Disabilities: The Linkage between COPD and Frailty.
    Oishi K; Matsunaga K; Harada M; Suizu J; Murakawa K; Chikumoto A; Ohteru Y; Matsuda K; Uehara S; Hamada K; Ohata S; Murata Y; Yamaji Y; Asami-Noyama M; Edakuni N; Kakugawa T; Hirano T
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33172080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY.
    Corren J; Garcia Gil E; Griffiths JM; Parnes JR; van der Merwe R; Sałapa K; O'Quinn S
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):187-193. PubMed ID: 33169672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.